Chimeric Antigen Receptor (CAR) T-Cell Immunot... - CLL Support
Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy for Leukemia and Beyond
You need to be a member of this community to see this post.
Read more about...
You need to be a member of this community to see hidden responses.
Not what you're looking for?
You may also like...
More CAR-T: Looking Back to Go Forward in CAR-T Cell Therapy in R/R CLL
Long-term data from a phase 1 study investigating anti-CD19 chimeric antigen receptor (CAR) T-cell...
Ibrutinib enhances chimeric antigen receptor T-cell engraftment and efficacy in leukemia
"In this study, we demonstrated that ibrutinib treatment enhances the feasibility of generating CAR...
Medicare will begin nationwide coverage of CAR T-cell therapy
Medicare will begin nationwide coverage of CAR T-cell therapy, a complicated treatment for some...
The current status and challenges of CAR-T therapy in CLL
A few members of this group are scheduled for CAR-T and others might find themselves in the same...
EHA 2019: Dr. Maloney on CAR-T and Dr. Davids of Chemo-Immunotherapy combinations
David Maloney is world expert in CAR-T therapy and was one of my doctors when I got my genetically...
T cell leukemia 
Dr Sharman provides an update on an NIH CAR-T trial for relapsed/refractory DBLC
POST 6 CAR-T cell therapy
